Abstract
Animal experiments have indicated that noradrenergic agents can improve the recovery from stroke. In this double-blind placebo-controlled crossover study, hemiparetic chronic stroke patients (n = 10) received a single dose of the noradrenaline reuptake inhibitor reboxetine or placebo. Then the patients participated in one hour of physiotherapy focused on function of the paretic hand. Three different motor assessments (tapping speed, grip strength, dexterity evaluation) were performed before drug intake, 1.5 hours later and after the physiotherapy session. Transcranial magnetic stimulation (TMS) was used to investigate motor excitability by measuring motor thresholds and amplitudes of motor evoked potentials. Both hands were studied. Compared with placebo, reboxetine ingestion was followed by an increase of tapping speed and grip strength in the paretic but not in the unaffected hand. No further improvement was noticed after physiotherapy. TMS results and dexterity measurements remained unchanged. We conclude that reboxetine improved simple hand functions in chronic stroke patients. Reboxetine should be considered as an additional tool in neurorehabilitation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Broeks JG, Lankhorst GJ, Rumping K, Prevo AJ (1999) The long-term outcome of arm function after stroke: results of a follow-up study. Disabil Rehabil 21:357–364
Feeney DM, De Smet AM, Rai S (2004) Noradrenergic modulation o hemiplegia: Facilitation and maintenance of recovery. Restor Neurol Neurosci 22:175–190
Fleishaker JC (2000) Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression. Clin Pharmacokinet 39:413–427
Herwig U, Bräuer K, Connemann B, Spitzer M, Schönfeldt-Lecuona C (2002) Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology 164:228–232
Kwakkel G, Wagenaar RC, Koelman TW, Lankhorst GJ, Koetsier JC (1997) Effects of intensity of rehabilitation after stroke. Stroke 28:1550–1556
Liepert J, Kotterba S, Tegenthoff M, Malin J-P (1996) Central fatigue assessed by transcranial magnetic stimulation. Muscle Nerve 19:1429–1434
Plewnia C, Hoppe J, Hiemke C, Bartels M, Cohen LG, Gerloff C (2002) Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci Lett 330:231–234
Plewnia C, Hoppe J, Cohen LG, Gerloff C (2004) Improved motor skill acquisition after selective stimulation of central norepinephrine. Neurology 62:2124–2126
Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lücking CH, Maertens de Noordhout AL, Marsden CD, Murray NMF, Rothwell JC, Swash M, Tomberg C (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79–92
Wade DT (1989) Measuring arm impairment and disability after stroke. Int Disabil Stud 11:89–92
Acknowledgments
This study was supported by Kompetenznetz Schlaganfall (grant 01GI9917 to J. Liepert and C. Weiller). We thank the physiotherapists Mrs Macus and Mrs Krüger for their support.
Author information
Authors and Affiliations
Corresponding author
Additional information
Received in revised form: 9 June 2006
Rights and permissions
About this article
Cite this article
Zittel, S., Weiller, C. & Liepert, J. Reboxetine improves motor function in chronic stroke. J Neurol 254, 197–201 (2007). https://doi.org/10.1007/s00415-006-0326-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0326-5